Advances in Diagnosis and Management of Cutaneous Adverse Drug Reactions

Chapter 1 Introduction: Classification, Terminology, Epidemiology, and Etiology of Cutaneous Adverse Drug Reactions

Chapter 2 Immunology of Cutaneous Adverse Drug Reactions

Chapter 3 Pharmacogenomics and Cutaneous Adverse Drug Reactions

Chapter 4 Viral Reactivation in Cutaneous Adverse Drug Reactions

Chapter 5 Using Technology to Learn About Immunology of Cutaneous Adverse Drug Reactions

Chapter 6 Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis (Epithelial Necrolysis)

Chapter 7 Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS)

Chapter 8 Acute Generalized Exanthematous Pustulosis

Chapter 10 Dermatologic Adverse Events from Cancer Treatments

Chapter 11 Cutaneous Adverse Drug Reactions in Pediatric Population

Chapter 12 Cutaneous Drug Reactions in the Elderly

Chapter 13 Cutaneous Adverse Drug Reactions in Human Immunodeficiency Virus Infection

Chapter 14 Cutaneous Adverse Drug Reactions from Antituberculosis Treatment

Chapter 15 Practical Approach to Diagnosis and Management of Cutaneous Adverse Drug Reactions

Chapter 16 Histopathology of Severe Drug Eruptions

Chapter 17 Evaluation of Drug Safety Literature: A Guide for the Practicing Dermatologist

Chapter 18 In Vitro and In Vivo Tests in Cutaneous Adverse Drug Reactions

Chapter 19 Pharmacovigilance of Cutaneous Adverse Drug Reactions

Chapter 20 Future Directions and Unmet Research Needs in Cutaneous Adverse Drug Reactions

Chapter 21 Atlas of Cutaneous Adverse Drug Reactions